Table 2.
Associations of Physician-Diagnosed Sleep Apnea, Self-Reported Habitual Snoring, and Other Potential Confounders or Mediators With Incident Atrial Fibrillation in the Overall Sleep Cohort (Multivariate Models), Multi-Ethnic Study of Atherosclerosis, 2000–2011
Variable | Model 1a |
Model 2b |
Model 3c |
Model 4d |
||||
---|---|---|---|---|---|---|---|---|
HR | 95% CI | HR | 95% CI | HR | 95% CI | HR | 95% CI | |
Age, years | 1.09e | 1.07, 1.11 | 1.08e | 1.06, 1.10 | 1.08e | 1.06, 1.10 | 1.08e | 1.06, 1.10 |
Male sex | 2.03e | 1.44, 2.93 | 2.11e | 1.50, 2.98 | 2.12e | 1.50, 2.98 | 2.02e | 1.43, 2.86 |
Black race/ethnicity | 0.47e | 0.32, 0.69 | 0.47e | 0.32, 0.68 | 0.46e | 0.32, 0.67 | 0.46e | 0.32, 0.68 |
Hispanic race/ethnicity | 0.55e | 0.34, 0.88 | 0.53e | 0.33, 0.86 | 0.53e | 0.33, 0.86 | 0.55e | 0.34, 0.89 |
Body mass indexf | 1.03 | 1.00, 1.06 | 1.02 | 0.99, 1.05 | 1.01 | 0.98, 1.05 | 1.01 | 0.98, 1.04 |
Systolic blood pressure, mm Hg | 1.01 | 1.00, 1.01 | 1.01 | 1.00, 1.01 | 1.01 | 1.00, 1.01 | 1.01 | 1.00, 1.01 |
Use of antihypertensive agents | 1.60e | 1.20, 2.16 | 1.59e | 1.18, 2.13 | 1.58e | 1.18, 2.12 | 1.55e | 1.15, 2.08 |
Use of lipid-lowering agents | 0.63e | 0.44, 0.93 | 0.65e | 0.45, 0.95 | 0.65e | 0.45, 0.96 | 0.65e | 0.44, 0.95 |
Chronic kidney disease | 1.47e | 1.03, 2.11 | 1.46e | 1.02, 2.09 | 1.48e | 1.03, 2.12 | 1.43e | 1.00, 2.05 |
Log interleukin-6, pg/mL | 1.44e | 1.14, 1.82 | 1.44e | 1.14, 1.82 | 1.41e | 1.12, 1.79 | ||
Electrocardiographic LAE | 1.32 | 0.94, 1.85 | 1.33 | 0.95, 1.86 | ||||
Interim CHD or heart failure | 3.04e | 2.04, 4.53 | ||||||
Habitual snoring | 1.02 | 0.72, 1.44 | 1.02 | 0.72, 1.44 | 1.02 | 0.72, 1.45 | 1.08 | 0.76, 1.54 |
Sleep apnea | 1.76e | 1.03, 3.02 | 1.74e | 1.01, 2.99 | 1.67 | 0.97, 2.88 | 1.52 | 0.88, 2.63 |
Abbreviations: CHD, coronary heart disease; CI, confidence interval; HR, hazard ratio; LAE, left atrial enlargement.
a Adjusted for age, sex, race/ethnicity, study site, health insurance status, educational level, body mass index, diabetes, systolic blood pressure, total and high-density lipoprotein cholesterol, chronic kidney disease, smoking status, alcohol intake status, use of antihypertensive agents, and use of lipid-lowering agents.
b Additionally adjusted for log interleukin-6.
c Additionally adjusted for electrocardiographic LAE.
d Additionally adjusted for interim CHD or heart failure events.
e P < 0.05.
f Weight (kg)/height (m)2.